The Oncology Institute, Inc. (TOI)

The Oncology Institute Statistics

Total Valuation

TOI has a market cap or net worth of $369.74 million. The enterprise value is $442.60 million.

Market Cap	369.74M
Enterprise Value	442.60M

Important Dates

The last earnings date was Wednesday, August 13, 2025, after market close.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

TOI has 90.18 million shares outstanding. The number of shares has increased by 2.45% in one year.

Current Share Class	90.18M
Shares Outstanding	90.18M
Shares Change (YoY)	+2.45%
Shares Change (QoQ)	+1.91%
Owned by Insiders (%)	8.20%
Owned by Institutions (%)	25.36%
Float	67.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.77
Forward PS	1.55
PB Ratio	71.93
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.04
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.62

Current Ratio	1.62
Quick Ratio	1.33
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4.33

Financial Efficiency

Return on equity (ROE) is -651.69% and return on invested capital (ROIC) is -23.98%.

Return on Equity (ROE)	-651.69%
Return on Assets (ROA)	-17.27%
Return on Invested Capital (ROIC)	-23.98%
Return on Capital Employed (ROCE)	-49.36%
Revenue Per Employee	$514,395
Profits Per Employee	-$65,735
Employee Count	825
Asset Turnover	2.50
Inventory Turnover	26.61

Taxes

Income Tax	-131,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +745.36% in the last 52 weeks. The beta is 0.11, so TOI's price volatility has been lower than the market average.

Beta (5Y)	0.11
52-Week Price Change	+745.36%
50-Day Moving Average	3.09
200-Day Moving Average	1.60
Relative Strength Index (RSI)	65.50
Average Volume (20 Days)	2,020,392

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TOI had revenue of $424.38 million and -$54.23 million in losses. Loss per share was -$0.67.

Revenue	424.38M
Gross Profit	63.75M
Operating Income	-46.90M
Pretax Income	-57.85M
Net Income	-54.23M
EBITDA	-40.04M
EBIT	-46.90M
Loss Per Share	-$0.67

Balance Sheet

The company has $30.29 million in cash and $103.16 million in debt, giving a net cash position of -$72.86 million or -$0.81 per share.

Cash & Cash Equivalents	30.29M
Total Debt	103.16M
Net Cash	-72.86M
Net Cash Per Share	-$0.81
Equity (Book Value)	-8.99M
Book Value Per Share	-0.10
Working Capital	40.01M

Cash Flow

In the last 12 months, operating cash flow was -$10.19 million and capital expenditures -$2.89 million, giving a free cash flow of -$19.15 million.

Operating Cash Flow	-10.19M
Capital Expenditures	-2.89M
Free Cash Flow	-19.15M
FCF Per Share	-$0.21

Margins

Gross margin is 15.02%, with operating and profit margins of -11.05% and -15.53%.

Gross Margin	15.02%
Operating Margin	-11.05%
Pretax Margin	-15.56%
Profit Margin	-15.53%
EBITDA Margin	-9.43%
EBIT Margin	-11.05%
FCF Margin	n/a

Dividends & Yields

TOI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.45%
Shareholder Yield	-2.45%
Earnings Yield	-14.67%
FCF Yield	-5.18%

Analyst Forecast

The average price target for TOI is $6.00, which is 46.34% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	46.34%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3